this post was submitted on 05 Jan 2026
1 points (100.0% liked)

China News

91 readers
1 users here now

A community for china news

founded 3 months ago
MODERATORS
rss@news.abolish.capital
Salamence@lemmy.zip
RedWizard@news.abolish.capital
1
The ‘biology winter’ thaws: why investors are piling into Hong Kong’s biotech IPOs (www.scmp.com)
submitted 1 month ago by rss@news.abolish.capital to c/china@news.abolish.capital
0 comments fedilink hide all child comments
 

Hong Kong’s biotech fundraising momentum is expected to extend into 2026, as licensing deals and strong post-initial public offering (IPO) trading last year persuaded investors that China’s drug developers are worth backing again – even before they generate revenue. “Chinese innovation drugs expanding into overseas markets have become the industry mainstream, indicating the domestic innovation sector has entered its harvest phase,” said Felix Huang, head of equity at Oakwise Capital. “New trends...

From China - South China Morning Post via This RSS Feed.

no comments (yet)
sorted by: hot top controversial new old
there doesn't seem to be anything here